Joel Isaacson & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,302
Closed -$1.02M 215
2019
Q3
$1.02M Sell
10,302
-14
-0.1% -$1.33K 0.15% 72
2019
Q2
$954K Sell
10,316
-462
-4% -$43.9K 0.14% 73
2019
Q1
$1.02M Buy
10,778
+150
+1% +$13.1K 0.15% 81
2018
Q4
$929K Sell
10,628
-474
-4% -$35K 0.15% 82
2018
Q3
$994K Hold
11,102
0.16% 67
2018
Q2
$882K Sell
11,102
-3,060
-22% -$254K 0.15% 73
2018
Q1
$1.26M Hold
14,162
0.22% 48
2017
Q4
$1.48M Hold
14,162
0.26% 44
2017
Q3
$2.06M Sell
14,162
-500
-3% -$68.1K 0.38% 31
2017
Q2
$1.9M Sell
14,662
-400
-3% -$49K 0.36% 33
2017
Q1
$1.87M Hold
15,062
0.37% 33
2016
Q4
$1.74M Hold
15,062
0.35% 34
2016
Q3
$1.57M Hold
15,062
0.32% 34
2016
Q2
$1.49M Sell
15,062
-91
-0.6% -$9.41K 0.32% 33
2016
Q1
$1.52M Hold
15,153
0.34% 34
2015
Q4
$1.81M Sell
15,153
-300
-2% -$34.7K 0.45% 26
2015
Q3
$1.67M Sell
15,453
-751
-5% -$93.2K 0.45% 26
2015
Q2
$1.88M Sell
16,204
-11,624
-42% -$1.33M 0.48% 23
2015
Q1
$3.21M Sell
27,828
-458
-2% -$54.7K 0.81% 14
2014
Q4
$3.16M Sell
28,286
-117
-0.4% -$12.3K 0.85% 14
2014
Q3
$2.69M Sell
28,403
-553
-2% -$49.9K 0.82% 16
2014
Q2
$2.49M Buy
28,956
+2,926
+11% +$223K 0.78% 18
2014
Q1
$1.82M Sell
26,030
-1,000
-4% -$79.2K 0.61% 22
2013
Q4
$2.28M Buy
27,030
+1,000
+4% +$79.1K 0.83% 18
2013
Q3
$2.01M Buy
26,030
+3,200
+14% +$224K 0.82% 18
2013
Q2
$1.33M Buy
+22,830
New +$1.37M 0.63% 21

Other funds holding CELG

Joel Isaacson & Co's CELG Position: Q4 2019 in Review

Joel Isaacson & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,302 shares — an estimated $1.02M sold.

Joel Isaacson & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.21M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Joel Isaacson & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Joel Isaacson & Co sold 10,302 Celgene Corp shares in Q4 2019, an estimated $1.02M.
  • Joel Isaacson & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Joel Isaacson & Co's Celgene Corp position peaked at $3.21M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Joel Isaacson & Co's 13F filing for Q4 2019, filed 24 Jan 2020.